GlassScriptPhysician profile
Dong Hui Kang
NPI 1144310913
$6,935.56
in general payments reported to CMS, 2019-2025
42 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $614 · 2021: $1,114 · 2022: $738 · 2023: $949 · 2024: $1,302 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,449.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,260.15 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,132.08 | 2020-2025 | |
| Lilly USA, LLC | $811.71 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $699.10 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $624.25 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $206.09 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $203.76 | 2019-2024 | Eliquis |
| Amgen INC. | $166.87 | 2019-2025 | Evenity |
| Janssen Pharmaceuticals, INC | $149.03 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $144.49 | 2019-2024 | Trintellix |
| Sanofi-Aventis U.S. LLC | $121.63 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $110.18 | 2019-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $108.44 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.20 | 2019-2024 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $95.66 | 2023-2025 | Voquezna |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dong Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.